Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir
Clinical trial NCT05731843 · COMPLETED
Trial details
- NCT number
- NCT05731843
- Sponsor
- Atea Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2023-03-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.